Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration

Nature Genetics

Volumn 36, Issue 9, 2004, Pages 969-977

  Mohammed, Fazilat F ^a   Smookler, David S ^a   Taylor, Suzanne E M ^a   Fingleton, Barbara ^b   Kassiri, Zamaneh ^a   Sanchez, Otto H ^a   English, Jane L ^a   Matrisian, Lynn M ^b   Au, Billie ^a   Yeh, Wen Chen ^a   Khokha, Rama ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; NEUTRALIZING ANTIBODY; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR ANTIBODY;

ADOLESCENT; AGED; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL DEATH; CHRONIC OBSTRUCTIVE HEPATITIS; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; GENE; GENE DELETION; HEPATITIS; INJURY; KNOCKOUT MOUSE; LIVER CELL; LIVER FAILURE; LIVER NECROSIS; LIVER REGENERATION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TIMP1 GENE; TIMP3 GENE; TISSUE REACTION; TNFRSF1 GENE;

ADAM PROTEINS; AGING; ANIMALS; APOPTOSIS; CELL CYCLE; HEPATECTOMY; HEPATITIS, CHRONIC; LIVER; LIVER REGENERATION; METALLOENDOPEPTIDASES; MICE; MICE, MUTANT STRAINS; PROTEINS; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 4444229437     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1413     Document Type: Article

References (50)

1. Weber, B.H., Vogt, G., Pruett, R.C., Stohr, H. & Felbor, U. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat. Genet. 8, 352-356 (1994).
2. Leco, K.J. et al. Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J. Clin. Invest. 108, 817-829 (2001).
3. Fata, J.E. et al. Accelerated apoptosis in the Timp-3-deficient mammary gland. J. Clin. Invest. 108, 831-841 (2001).
4. Amour, A. et al. TNF-α converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett. 435, 39-44 (1998).
5. Lee, M.H., Knauper, V., Becherer, J.D. & Murphy, G. Full-length and N-TIMP-3 display equal inhibitory activities toward TNF-α convertase. Biochem. Biophys. Res. Commun. 280, 945-950 (2001).
6. Black, R.A. et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 385, 729-733 (1997).
7. Moss, M.L. et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385, 733-736 (1997).
8. Peschon, J.J. et al. An essential role for ectodomain shedding in mammalian development. Science 282, 1281-1284 (1998).
9. Killar, L., White, J., Black, R. & Peschon, J. Adamalysins. A family of metzincins including TNF-α converting enzyme (TACE). Ann. NY Acad. Sci. 878, 442-452 (1999).
10. Rovida, E., Paccagnini, A., Del Rosso, M., Peschon, J. & Dello Sbarba, P. TNF-α-converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation. J. Immunol. 166, 1583-1589 (2001).
11. Contin, C. et al. Membrane-anchored CD40 is processed by the tumor necrosis factorα-converting enzyme. Implications for CD40 signaling. J. Biol. Chem. 278, 32801-32809 (2003).
12. Lee, D.C. et al. TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase. Ann. N. Y. Acad. Sci. 995, 22-38 (2003).
13. Aggarwal, B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3, 745-756 (2003).
14. Chen, G. & Goeddel, D.V. TNF-R1 signaling: a beautiful pathway. Science 296, 16341635 (2002).
15. Gearing, A.J. et al. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 370, 555-557 (1994).
16. McGeehan, G.M. et al. Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor. Nature 370, 558-561 (1994).
17. Nuttatl, R.K. et al. Expression analysis of the entire MMP and TIMP gene families during mouse tissue development. FEBS Lett. 563, 129-134 (2004).
18. Knittel, T. et al. Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-α and TGF-β1. J. Hepatol. 30, 48-60 (1999).
19. Aldeguer, X. et al. Interleukin-6 from intrahepatic cells of bone marrow origin is required for normal murine liver regeneration. J. Hepatol. 35, 40-48 (2002).
20. Rizvi, N.A. et al. A phase I study of oral BMS-275291, a novel nonhydroxamate sheddase-sparing matrix metalloproteinase inhibitor, in patients with advanced or metastatic cancer. Clin. Cancer Res. 10, 1963-1970 (2004).
21. d'Ortho, M.P. et al. Membrane-type matrix metalloproteinases 1 and 2 exhibit broadspectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur. J. Biochem. 250, 751-757 (1997).
22. English, W.R. et al. Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-α convertase activity but does not activate pro-MMP2. J. Biol. Chem. 275, 4046-4055 (2000).
23. Haro, H. et al. LM. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-α in a model of herniated disc resorption. J. Clin. Invest. 105, 143-150 (2000).
24. Ghosh, S., May, M.J. & Kopp, E.B. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260 (1998).
25. Beg, A.A., Sha, W.C., Bronson, R.T., Ghosh, S. & Baltimore, D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376, 167-170 (1995).
26. Alcamo, E. et al. Targeted mutation of TNF receptor 1 rescues the RelA-deficient mouse and reveals a critical role for NF-κB in leukocyte recruitment. J. Immunol. 167, 1592-1600 (2001).
27. Yamada, Y., Kirillova, I., Peschon, J.J. & Fausto, N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl. Acad. Sci. USA 94, 1441-1446 (1997).
28. Jevon, G.P. Grade and stage of chronic hepatitis. Pediat. Dev. Pathol. 4, 372-380 (2001).
29. Toyonaga, T. et al. Chronic active hepatitis in transgenic mice expressing interferon-γ in the liver. Proc. Natl. Acad. Sci. USA 91, 614-618 (1994).
30. Michalopoulos, G.K. & DeFrances, M.C. Liver regeneration. Science 276, 60-66 (1997).
31. Fausto, N. Liver regeneration. J. Hepatol. 32, 19-31 (2000).
32. Kyriakis, J.M. Life-or-death decisions. Nature 414, 265-266 (2001).
33. Ricote, M., Li, A.C., Willson, T.M., Kelly, C.J. & Glass, C.K. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391, 79-82 (1998).
34. Jiang, C., Ting, A.T. & Seed, B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82-86 (1998).
35. Bzowska, M., Jura, N., Lassak, A., Black, R.A. & Bereta, J. Tumor necrosis factor-α stimulates expression of TNF-α converting enzyme in endothelial cells. Eur. J. Biochem. 271, 2808-2820 (2004).
36. Blenis, J. & Hawkes, S.P. Characterization of a transformation- sensitive protein in the extracellular matrix of chicken embryo fibroblasts. J. Biol. Chem. 259, 11563-11570 (1984).
37. Georgopoulos, S., Plows, D. & Kollias, G. Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. J. Inflamm. 46, 86-97 (1996).
38. Mueller, C. et al. Noncleavable transmembrane mouse tumor necrosis factor-α (TNFα) mediates effects distinct from those of wild-type TNFα in vitro and in vivo. J. Biol. Chem. 274, 38112-38118 (1999).
39. Ruuls, S.R. et al. Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity 15, 533-543 (2001).
40. Nathan, C. Points of control in inflammation. Nature 420, 846-852 (2002).
41. Bouwens, L. Structural and functional aspects of Kupffer cells. Revis. Biol. Celular 16, 69-94 (1988).
42. b-tsA58 mice. J. Leukoc. Biol. 74, 49-59 (2003).
43. Kontoyiannis, D., Pasparakis, M., Pizarro, T.T., Cominelli, F. & Kollias, G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10, 387-398 (1999).
44. Butler, D.M. et al. DBA/1 mice expressing the human TNF-α transgene develop a severe, erosive arthritis: characterization of the cytokine cascade and cellular composition. J. Immunol. 159, 2867-2876 (1997).
45. Yeow, K.M. et al. Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix. Matrix Biol. 21, 75-88 (2002).
46. Qi, J.H. et al. Expression of Sorsby's fundus dystrophy mutations in human retinal pigment epithelial cells reduces matrix metalloproteinase inhibition and may promote angiogenesis. J. Biol. Chem, 277, 13394-13400 (2002).
47. Ambati, J. et al. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat. Med. 9, 1390-1397 (2003).
48. Higgins, G.M. & Anderson, R.M. Restoration of the liver of the white rat following partial surgical removal. Arch. Pathol. 12, 186-182 (1931).
49. Jin, G. et al. A continuous fluorimetric assay for tumor necrosis factor-γ converting enzyme. Anal. Biochem. 302, 269-275 (2002).
50. McIntyre, J.O. et al. Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumor-associated matrix metalloproteinase-7 activity. Biochem. J. 377, 617-628 (2004).